摘要
室性期前收缩是临床实践中常见的心律失常之一。大多数室性期前收缩患者没有临床症状。没有器质性心脏病的无症状性室性期前收缩患者预后相对较好,然而,频发的无症状性室性期前收缩可能与多种心血管事件和死亡风险增加有关,而且这类患者可能更倾向于发展成心动过速诱导的心肌病。因此,对无症状性室性期前收缩患者进行合理的临床评估至关重要。决定是否针对无症状性室性期前收缩进行治疗主要基于3个因素:基础心脏疾病、室性期前收缩的负荷、心功能状况。治疗室性期前收缩的方法主要包括药物治疗和导管消融治疗。导管消融治疗已经成为治疗室性期前收缩的安全有效的方法。
Premature ventricular complexes（ PVCs） are a common occurrence in clinical practice. In many patients with ectopic ventricular events manifest as asymptomatic,isolated PVCs that have a relatively benign prognosis in those without structural heart disease.However,frequent asymptomatic PVCs may be associated with a substantial increase in the risk of mortality,cardiovascular events,new-onset heart failure,transient ischemic accident,sudden and total cardiac death. In the patients who have frequent PVCs,the asymptomatic subjects tend to have tachycardia-induced cardiomyopathy at initial presentation. Appropriate clinical evaluation and investigations are important in assessing patients with asymptomatic PVCs,so that effective treatment can be targeted. The decision to treat asymptomatic PVCs,either pharmacologically or via catheter ablation,should be predicated on three factors： the concomitant structural heart disease,the burden of the PVCs,and the status of ventricular function. Catheter ablation has emerged as a safe and effective option for the treatment of PVCs.
出处
《心血管病学进展》
CAS
2015年第6期704-708,共5页
Advances in Cardiovascular Diseases
基金
介入超声去肾交感化安全性探索(81370440)
关键词
室性期前收缩
无症状
预后
治疗
导管消融
premature ventricular complexes
asymptomatic
prognosis
management
catheter ablation
